Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.

NCT02279147 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Systemic Inflammatory Response Syndrome
Jaundice, Obstructive

Interventions

DRUG: neostigmine methylsulfate，raceanisodamine hydrochloride

Sponsor

Wanqing Gu